Related Research Articles
The National Cancer Institute (NCI) coordinates the United States National Cancer Program and is part of the National Institutes of Health (NIH), which is one of eleven agencies that are part of the U.S. Department of Health and Human Services. The NCI conducts and supports research, training, health information dissemination, and other activities related to the causes, prevention, diagnosis, and treatment of cancer; the supportive care of cancer patients and their families; and cancer survivorship.
Edison T. Liu, M.D. is the former president and CEO of The Jackson Laboratory, and the former director of its NCI-designated Cancer Center (2012-2021). As CEO of The Jackson Laboratory, the organization doubled revenue, faculty and personnel, expanded globally from two campuses to six, established 13 endowed chairs, and increased the institutional endowment by five-fold. He is currently a Professor and Honorary Fellow at the institution. Before joining The Jackson Laboratory, he was the founding executive director of the Genome Institute of Singapore (GIS), chairman of the board of the Health Sciences Authority, and president of the Human Genome Organization (HUGO) (2007-2013). As the executive director of the GIS, he brought the institution to international prominence as one of the most productive genomics institutions in the world.
John E. Niederhuber, MD was the 13th director of the National Cancer Institute (NCI), from 2006 until July, 2010, succeeding Andrew von Eschenbach, who went on to become a director at biotechnology firm BioTime. A nationally renowned surgeon and researcher, Dr. Niederhuber has dedicated his four-decade career to the treatment and study of cancer - as a professor, cancer center director, National Cancer Advisory Board chair, external advisor to the NCI, grant reviewer, and laboratory investigator supported by NCI and the National Institutes of Health. He is now Executive Vice President/CEO Inova Translational Medicine Institute and Inova Health System and co-director, Johns Hopkins Clinical Research Network.
Otis Webb Brawley is an American physician and the Bloomberg Distinguished Professor of Oncology and Epidemiology at Johns Hopkins University. He served as Chief Medical and Scientific Officer and Executive Vice President of the American Cancer Society from July 2007 to November 2018. He is board certified in internal medicine and medical oncology and is a Master of the American College of Physicians, Fellow of the American Society of Clinical Oncology, and a Fellow of the American College of Epidemiology. He is a member of the Institute of Medicine now known as the National Academy of Medicine.
Xifeng Wu is a Chinese-American cancer epidemiologist known for her cohort studies designed to discover the causes of cancer. She has been Dean of the School of Public Health of Zhejiang University since March 2019. She previously served as Director of the Center for Public Health and Translational Genomics and the Betty B. Marcus Chair in Cancer Prevention at the University of Texas MD Anderson Cancer Center until she was forced to resign in January 2019, as part of the Trump administration's push to counter Chinese influence in American research according to Bloomberg Businessweek.
Christina Messineo Annunziata is an American medical oncologist researching molecular signal transduction in ovarian cancer. She is an investigator in the National Cancer Institute's women's malignancies branch and head of the translational genomics section.
Worta J. McCaskill-Stevens is an American physician-scientist and medical oncologist specialized in cancer disparities research, management of comorbidities within clinical trials, and molecular research for cancer prevention interventions. She is chief of the community oncology and prevention trials research group at the National Cancer Institute.
Folakemi Titilayo Odedina is a Nigerian-born scientist and professor of pharmacy and medicine at the University of Florida. She is the principal investigator for the Prostate Cancer Transatlantic Consortium (CaPTC), a clinical research group using genomic science and environmental etiology to exploring disproportionate burden of prostate cancer among Black men funded by the NCI. She is a member of American Cancer Society's National Prostate Cancer Disparities Advisory Team.
Xiaohong Rose Yang is an American biomedical scientist researching the genetics of dysplastic nevus syndrome and chordoma, and etiologic heterogeneity of breast cancer. She is a senior investigator at the National Cancer Institute. Yang leads breast cancer studies in mainland China, Hong Kong, and Malaysia.
Katrina A. Blouke Goddard is an American genetic epidemiologist and biostatistician specializing in public health genomics and the translation of genomic applications into clinical practice. Goddard is the director of the division of cancer control and population sciences (DCCPS) at the National Cancer Institute (NCI). She was previously the distinguished investigator and director of translational and applied genomics at the Kaiser Permanente Center for Health Research and a faculty member at Case Western Reserve University.
Sharon A. Savage is an American pediatric hematologist/oncologist. She is the clinical director of the National Cancer Institute's Division of Cancer Epidemiology and Genetics.
Jennifer T. Loud is an American nurse practitioner who served as the assistant chief of the National Cancer Institute's clinical genetics branch until August 2020.
Rachael Zoe Stolzenberg-Solomon is an American epidemiologist and dietitian. She is a senior investigator and head of the metabolic epidemiology branch at the National Cancer Institute.
Maria Teresa Landi is an Italian epidemiologist and oncologist who researches genetic and environmental determinants of lung cancer and melanoma. At the National Cancer Institute, she is a senior investigator in the integrative tumor epidemiology branch and a senior advisor for genomic epidemiology. Landi is an associate professor of epidemiology at the Johns Hopkins Bloomberg School of Public Health.
Margaret Anne Tucker is an American oncologist and physician-scientist specialized in environmental and genetic epidemiology, familial cancers, and melanomas. She is a scientist emeritia at the National Cancer Institute (NCI). Tucker was a commissioned officer in the United States Public Health Service Commissioned Corps and served as director of the NCI human genetics program from 2005 until her retirement in June 2018.
Megan A. Clarke is an American cancer epidemiologist who researches anogenital and endometrial cancers. She is a Stadtman investigator in the clinical genetics branch at the National Cancer Institute.
Julia C. Gage is an American cancer epidemiologist who researches cervical screening and the human papillomavirus infection. She is a staff scientist in the clinical genetics branch at the National Cancer Institute.
Aimée Rebecca Kreimer is an American cancer epidemiologist who researches the etiology and prevention of human papillomavirus infection (HPV) and cancer prevention. She is a senior investigator in the infections and immunoepidemiology branch at the National Cancer Institute.
Ludmila Prokunina-Olsson is a molecular medical geneticist who conducts genetic and functional analyses downstream of genome-wide association studies (GWAS) for various human traits, including cancer, immune and infectious diseases. She is chief of the Laboratory of Translational Genomics (LTG) at the National Cancer Institute.
Sonja Ingrid Berndt is an American pharmacologist and cancer epidemiologist who researches non-Hodgkin lymphoma, prostate cancer, and anthropometric traits that are cancer risk factors. She is a senior investigator in the occupational and environmental epidemiology branch at the National Cancer Institute.
References
- 1 2 3 4 5 6 7 8 "Kathy J. Helzlsouer, MD, MHS, Associate Director | EGRP/DCCPS/NCI/NIH". epi.grants.cancer.gov. Retrieved 2022-10-29.
This article incorporates text from this source, which is in the public domain . - ↑ "Cancer Epidemiology and Genomics Research – Kathy J. Helzlsouer, M.D., M.H.S. - NCI". www.cancer.gov. Retrieved 2022-10-29.
This article incorporates public domain material from websites or documents of the National Institutes of Health.| General | |
|---|---|
| Scientific databases | |
